Current rheumatology reviews · 2026
Secondary Factor X Deficiency Associated with Sjögren's Syndrome: A Rare Case Report.
Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Keskin Dilek, Candan Ozlem
Аннотация
BACKGROUND: Acquired factor X deficiency (AFXD) is considered a rare but clinically significant cause of coagulation disorders, predominantly associated with systemic AL amyloidosis. Autoimmune-mediated AFXD is very rare, and a clear, well-documented association with Sjögren's syndrome has not yet been reported.
CASE PRESENTATION: A 60-year-old woman with hypertension presented with chest pain. Despite normal liver function and absence of monoclonal gammopathy, she was found to have significantly prolonged PT/INR and severe factor X deficiency (3%). During follow-up, she developed symptoms of dry eyes, and autoimmune serology was positive for ANA, anti-SSA, and anti-SSB, meeting the 2016 ACR/EULAR criteria for Sjögren's syndrome. After ruling out alternative causes, she was diagnosed with autoimmune-mediated AFXD. Despite the severe deficiency, she did not present with any significant bleeding symptoms. Prednisone treatment (1 mg/kg/day) led to partial biochemical improvement.
CONCLUSION: This report describes the first known association between Sjögren's syndrome and AFXD. Furthermore, the case highlights the importance of considering autoimmune etiologies in cases of unexplained coagulopathy and demonstrates the disconnect between laboratory abnormalities and bleeding phenotypes.
CASE PRESENTATION: A 60-year-old woman with hypertension presented with chest pain. Despite normal liver function and absence of monoclonal gammopathy, she was found to have significantly prolonged PT/INR and severe factor X deficiency (3%). During follow-up, she developed symptoms of dry eyes, and autoimmune serology was positive for ANA, anti-SSA, and anti-SSB, meeting the 2016 ACR/EULAR criteria for Sjögren's syndrome. After ruling out alternative causes, she was diagnosed with autoimmune-mediated AFXD. Despite the severe deficiency, she did not present with any significant bleeding symptoms. Prednisone treatment (1 mg/kg/day) led to partial biochemical improvement.
CONCLUSION: This report describes the first known association between Sjögren's syndrome and AFXD. Furthermore, the case highlights the importance of considering autoimmune etiologies in cases of unexplained coagulopathy and demonstrates the disconnect between laboratory abnormalities and bleeding phenotypes.